Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

CVS Health on Wednesday named Steve Nelson, a former UnitedHealth insurance head, to run its Aetna business, where rising ...

For CVS, this year has been defined by an unsuccessful fight against elevated medical costs. The third quarter was no different. “We have been more acutely impacted than others in the industry ...

Cantor Fitzgerald analyst Sarah James maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...

TD Cowen analyst Charles Rhyee maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $85.00. The company’s shares closed yesterday at $61.61.

CVS reported mixed third-quarter results shadowed by heightened medical costs on Wednesday, in the massive healthcare enterprise’s first earnings report with new CEO David Joyner at the helm ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Longtime CVS Health executive David Joyner has replaced Karen Lynch as CEO, as the company struggles to drive higher profits and stock performance, CVS announced Friday. The move, effective ...

America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David Joyner replacing Karen Lynch. CVS also withdrew its 2024 profit ...

Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. Reviews ethics statement ...